Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. liquid biopsy
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Liquid Biopsy Articles & Analysis

11 articles found

Matched tumor-normal sequencing: The preferred method for identifying somatic mutations driving tumorigenesis

Matched tumor-normal sequencing: The preferred method for identifying somatic mutations driving tumorigenesis

Discover how matched tumor-normal sequencing can help clinical researchers detect the somatic origin of variants with certainty. In the era of precision oncology, it has become increasingly common for patients diagnosed with cancer to undergo tumor sequencing. Identifying the mutations that make up a tumor’s genomic landscape can help guide selection of targeted therapies and inform ...

BySOPHiA Genetics


From Data to Decisions, Faster than Ever: Pioneering the future of precision medicine with the New Generation SOPHiA DDM Platform

From Data to Decisions, Faster than Ever: Pioneering the future of precision medicine with the New Generation SOPHiA DDM Platform

In response to the emerging needs in global healthcare, SOPHiA GENETICS has just revealed the New Generation SOPHiA DDM™ Platform, aiming to stay at the forefront of precision medicine and address today the healthcare needs of tomorrow. ...

BySOPHiA Genetics


Guidelines Spotlight: ESMO urge NGS testing for additional advanced cancers

Guidelines Spotlight: ESMO urge NGS testing for additional advanced cancers

ESMO updated its recommendations for NGS in advanced cancers this year, urging broader use of NGS in additional cancer types and the inclusion of tumor-agnostic biomarkers. The ESMO Precision Medicine Working Group (PMWG) first published its recommendations for when to use next-generation sequencing (NGS) in routine practice for patients with metastatic cancers in 20201. At that time, based ...

BySOPHiA Genetics


Q&A: The evolving role of antibody-drug conjugates in oncology

Q&A: The evolving role of antibody-drug conjugates in oncology

Dr. Kate Sasser from Tempus led a discussion on the potential of antibody-drug conjugates (ADCs), their challenges in targeting tumor antigens, and the future of cancer treatment with Dr. Daniel Johnson, Dr. Funda Meric-Bernstam, and Dr. Kellogg Parsons. The oncology field is rapidly advancing with the development of antibody-drug conjugates (ADCs), offering new hope for ...

ByTempus


Case Study B - Liquid Biopsy

Case Study B - Liquid Biopsy

X-ZELL is collaborating with Singapore General Hospital (SGH) and the National University Hospital Singapore (NUH) to explore how X-ZELL single-cell diagnostics may aid in the early detection of clinically significant prostate cancer in whole blood. The prospectively blinded, 400-patient multi-centre study officially commenced in 2020 and will lay the foundation for the launch of a commercially ...

ByX-Zell Inc.


INOVIQ study validates the use of SubB2M as an aid in diagnosing malignant melanoma

INOVIQ study validates the use of SubB2M as an aid in diagnosing malignant melanoma

These findings support INOVIQ’s SubB2M diagnostics program developing blood tests for monitoring of breast, ovarian and other cancers. Commercialisation of liquid biopsy pipeline INOVIQ CEO Dr Leearne Hinch said: “INOVIQ remains focused on the development and commercialisation of its liquid biopsy pipeline of ...

ByINOVIQ Ltd


Nanostics Announces the Launch of its Bladder Cancer Clinical Study Identifying Disease Predictors for Early Detection of Bladder Cancer

Nanostics Announces the Launch of its Bladder Cancer Clinical Study Identifying Disease Predictors for Early Detection of Bladder Cancer

The aim of the study is to validate a novel and minimally invasive liquid biopsy test for bladder cancer diagnosis using Nanostics’ ClarityDX® diagnostic platform. ...

ByNanostics Inc.


Human Microbiome Research Promotes Progress of Precision Medicine

Human Microbiome Research Promotes Progress of Precision Medicine

With its development, more attention has been given to genetic testing related to a person's current health status, such as liquid biopsies. In recent years, the human microbiome has been found to reflect the health status of the human body at the level of the internal environment, especially for some chronic diseases. ...

ByCD Genomics


VisionGate’s New Website Illustrates its Mission to Save Lives through Early Detection of Lung Cancer

VisionGate’s New Website Illustrates its Mission to Save Lives through Early Detection of Lung Cancer

VisionGate, a Breakthrough Liquid-biopsy Technology Company, Leads the Battle Against Lung Cancer through Early Detection Technology with a Simple, Non-Intrusive Sputum Test. ...

ByVisionGate, Inc


Spanish Cancer Company Universal Dx to Commercialize Methylation Method for Lung Cancer Detection

Spanish Cancer Company Universal Dx to Commercialize Methylation Method for Lung Cancer Detection

NEW YORK - Spanish cancer research firm Universal Diagnostics is gearing up to commercialize a liquid biopsy test that applies methylation biomarkers to detect lung cancer, based on data presented at the International Association for the Study of Lung Cancer 2020 World Conference for Lung Cancer (WCLC) last month. ...

ByUniversal Diagnostics SL


Nanostics Re-Opens ClarityDX Prostate Clinical Study with New US Recruitment Site

Nanostics Re-Opens ClarityDX Prostate Clinical Study with New US Recruitment Site

Summary Nanostics' clinical validation study for ClarityDX Prostate, a liquid biopsy test for the early diagnosis of clinically significant prostate cancer, re-opens recruitment after lifting of COVID-19 research restrictions A top-ranked research institute in the Northeast US will now partner with Nanostics' by recruiting patients for the clinical ...

ByNanostics Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT